Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Ngā kaituhi matua: Tangui Barré (Author), Fabrice Carrat (Author), Clémence Ramier (Author), Hélène Fontaine (Author), Vincent Di Beo (Author), Morgane Bureau (Author), Céline Dorival (Author), Dominique Larrey (Author), Elisabeth Delarocque-Astagneau (Author), Philippe Mathurin (Author), Fabienne Marcellin (Author), Ventzislava Petrov-Sanchez (Author), Carole Cagnot (Author), Patrizia Carrieri (Author), Stanislas Pol (Author), Camelia Protopopescu (Author), the ANRS/AFEF Hepather study group (Author)
• Hōputu: Pukapuka
• I whakaputaina: BMC, 2022-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...